Clinical Trial Update: Efficacy and Safety Study of Meloxicam Versus Mefenamic Acid in Patients With Dysmenorrhea [Phase 2]

View source ↗

Summary

Phase 2 trial comparing meloxicam to mefenamic acid in dysmenorrhea completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dysmenorrhea

Drugs mentioned

• MEFENAMIC ACID (Mefenamic acid)
• MELOXICAM (MELOXICAM)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Dysmenorrhea | Phase 2 | Status: COMPLETED